Dataset Information

Association of Existence of Third Places and Role Model on Suicide Risk Among Adolescent in Japan: Results From A-CHILD Study.

ABSTRACT: Objective: Low self-esteem among adolescents can be considered a risk factor for suicidal behavior in adolescents. Thus, the purpose of this study is to investigate the association between the existence of a third place and role model on self-esteem among adolescents in Japan, where low self-esteem is prevalent among adolescents. Methods: We analyzed data from the 2016 Adachi Child Health Impact of Living Difficulty (A-CHILD) study, in which a school-based questionnaire was conducted among children in grades 4, 6, and 8 living in Adachi City, Tokyo (N = 1,609). Children self-rated their own levels of self-esteem. Low self-esteem was defined as lower 10 percentile group. The existence of a third place was defined as a place where children spent time after school other than the home or school campus, and role model was defined as having someone, other than a parent, who they looked up to, and these concepts were assessed via questionnaire. Results: Adolescents without a third place and role model accounted for 10.5 and 6.1%, respectively. We found that children who lacked a third place also showed a significant association with low self-esteem (OR: 1.75, 95% confidence interval (CI): 1.09-2.81), and those who lacked a role model were 3.34 times more likely to have lower self-esteem (95% CI: 1.98-5.62). Conclusion: The existence of a third place and a role model may be important to prevent low self-esteem among adolescents in Japan.

SUBMITTER: Fujiwara T

PROVIDER: S-EPMC7644899 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Association of Existence of Third Places and Role Model on Suicide Risk Among Adolescent in Japan: Results From A-CHILD Study.

Fujiwara Takeo T Doi Satomi S Isumi Aya A Ochi Manami M

Frontiers in psychiatry 20201023

<b>Objective:</b> Low self-esteem among adolescents can be considered a risk factor for suicidal behavior in adolescents. Thus, the purpose of this study is to investigate the association between the existence of a third place and role model on self-esteem among adolescents in Japan, where low self-esteem is prevalent among adolescents. <b>Methods:</b> We analyzed data from the 2016 Adachi Child Health Impact of Living Difficulty (A-CHILD) study, in which a school-based questionnaire was conduct ...[more]

PMID: 33192648

Similar Datasets

Project description:ObjectiveTo report functional outcomes from the multisite Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), which examined the impact of youth anxiety treatment (cognitive-behavioral therapy [CBT], coping cat; Sertraline, SRT; COMB [CBT + SRT]; pill placebo) on (a) global and (b) domain-specific functioning assessed an average of 3.1 times, 3- to 12-years postrandomization (first assessment = mean 6.5 years postrandomization).MethodThree-hundred and 19 of 488 families from the Child/Adolescent Anxiety Multimodal Study (CAMS; Walkup et al., 2008) participated. Growth curve modeling examined the impact of treatment condition and acute treatment outcomes (i.e., response, remission) on global functioning, global and domain-specific impairment, and life satisfaction across follow-up visits. Logistic regressions explored the impact of treatment remission and condition on low frequency events (arrests/convictions) and education.ResultsTreatment responders and remitters demonstrated better global functioning, decreased overall impairment, and increased life satisfaction at follow-up. Treatment remission, but not response, predicted decreased domain-specific impairment (social relationships, self-care/independence, academic functioning), and maintenance of increased life satisfaction across follow-ups. Participants in the CBT condition, compared with pill placebo, demonstrated improved trajectories pertaining to life satisfaction, overall impairment, and impairment in academic functioning. Randomization to CBT or COMB treatment was associated with increasing employment rates. Trajectories for participants randomized to SRT was not significantly different from placebo. Treatment outcome and condition did not predict legal outcomes, school/work variables, or family life.ConclusionPositive early intervention outcomes are associated with improved overall functioning, life satisfaction, and functioning within specific domains 6.5 years posttreatment. Treatment type differentially predicted trajectories of functioning. Findings support the positive impact of pediatric anxiety treatment into adolescence and early adulthood. (PsycINFO Database Record

Project description:ObjectiveThis meta-analysis examined suicide-related events in the acute phases of double-blind, placebo-controlled atomoxetine trials in pediatric and adult patients with attention-deficit/hyperactivity disorder (ADHD).MethodsA total of 3883 pediatric and 3365 adult patients were included. Potential events were identified from the adverse events database using a text-string search. Mantel-Haenszel risk ratios (MHRR) were calculated for potential suicide-related events categorized according to United States Food and Drug Administration defined codes.ResultsIn this data set, no completed suicides were reported in the pediatric or adult populations. One pediatric (attempted suicide) (and no adult patient events) was categorized as suicidal behavior in the atomoxetine group. The frequency of combined suicidal behavior or ideation with atomoxetine treatment was 0.37% in pediatric patients (vs. 0.07% with placebo) and 0.11% in adults (vs. 0.12% with placebo) and the risk compared with placebo was not statistically significant (MHRR=1.57; p=0.42 and MHRR=0.96; p=0.96, respectively). In pediatric patients, suicidal ideation only was reported more frequently compared with placebo (MHRR=1.63; p=0.41).ConclusionsOverall in this data set, no completed suicides and 1 pediatric patient suicidal behavior event were reported in atomoxetine-treated pediatric and adult patients. Suicidal ideation was uncommon among atomoxetine-treated pediatric and adult patients, although it was reported more frequently in atomoxetine-treated pediatric patients compared with placebo; the reporting rate difference was not statistically significant. The MHRR of suicidal ideation was consistent with a previous meta-analysis of similar design. There was no evidence of increased risk for suicidal behavior in atomoxetine-treated pediatric or adult patients.Clinical trial registration informationhttp://www.clinicaltrials.gov . The data reported are from an analysis of 23 pediatric and 9 adult clinical trials completed between 1998 and 2011. Ten pediatric (Studies HFBD, HFBK, LYAC, LYAS, LYAT, LYAW, LYAX, LYBG, LYBI, and LYBP) and two adult trials (Studies LYAA and LYAO) were conducted before the requirement to post trials at initiation (ongoing as of July 1, 2005) and, therefore, do not have a registration number. The registration numbers for the 13 pediatric trials meeting this requirement are: NCT00191698 (LYBX), NCT00486122 (LYCC), NCT00386581 (LYCZ), NCT00485459 (S010), NCT00191542 (LY15), NCT00191295 (LYBC), NCT00191906 (LYCK), NCT00192023 (LYCY), NCT00191945 (LYDM), NCT00546910 (LYDV), NCT00406354 (LYDW), NCT00380692 (S017), and NCT00607919 (LYEB). For the seven adult trials, the registration numbers are: NCT00190931 (LYBV), NCT00190957 (LYBY), NCT00190736 (LYCU), NCT00190775 (LYCW), NCT00190879 (LYDQ), NCT00510276 (LYDZ), and NCT00962104 (LYEE).

Dataset Information

Association of Existence of Third Places and Role Model on Suicide Risk Among Adolescent in Japan: Results From A-CHILD Study.

Publications

Association of Existence of Third Places and Role Model on Suicide Risk Among Adolescent in Japan: Results From A-CHILD Study.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets